Home / Categories / Miscellaneous / Samples / Throwback Thursday |
FILE 4/16 |
![]() |
|
Click here for details on how to download this file | |
|
|
When an antidepressant is not enough, add Seroquel XL. Seroquel XL is now licensed as add-on treatment for patients with major depressive disorder (MDD) who have had suboptimal response to antidepressant monotherapy. Prior to initiating treatment, clinicians should consider the safety profile of Seroquel XL. Brand name: Seroquel XL Generic name/category: quetiapine prolonged release Company: AstraZeneca Country/Market: UK, Europe Indication(s)/Category: Major Depression Disorder (MDD) Target: Healthcare Professionals (HCP) Tagline: none Medium: Print ad Size/duration: Double-page spread Publication/Aired: The British Journal Of Clinical Pharmacy - December 2010 To see more of this brand's ads, click here |
Rate this file (No vote yet) | |||||
File information | |
Download: | Available for users with full-size access enabled. |
Filename: | Seroquel_XL-TheBritishJournalOfClinicalPharmacy-December2010.jpg |
Keywords: | Seroquel brand , 2010 publication year , Seroquel XL , Seroquel , quetiapine prolonged release , Mental illness , Psychiatry , Psychology , Branded , AstraZeneca , UK , Europe , HCP , Prescription , double-page spread , print ad , English , Major Depression Disorder , MDD , Lots Balancing Copy , healthcare category , hcpUK , Blue color , Blue+color , Blue+color , pink color , illustration , clean layout , Pessimistic message , Published , camera , bedroom , depressed , bag , despair , bed , pillow , sheets , sitting , floor , hand , hands , toilet paper |
Filesize: | 3963 KiB |
Date added: | Dec 11, 2010 |
Dimensions: | 2813 x 2000 pixels |
URL: | https://adpharm.net/displayimage.php?pid=22940 |
My Collection: | Add to collection |